Abstract
Loss of function mutations in the gene encoding dystrophin elicits a hypersensitive fear response in mice and humans. In the dystrophin-deficient mdx mouse, this behaviour is partially protected by oestrogen, but the mechanistic basis for this protection is unknown. Here, we show that female mdx mice remain normotensive during restraint stress compared to a hypotensive and hypertensive response in male mdx and male/female wildtype mice, respectively. Partial dystrophin expression in female mdx mice (heterozygous) also elicited a hypertensive response. Ovariectomized (OVX) female mdx mice were used to explain the normotensive response to stress. OVX lowered skeletal muscle mass and lowered the adrenal mass and zona glomerulosa area (aldosterone synthesis) in female mdx mice. During a restraint stress, OVX dampened aldosterone synthesis and lowered the corticosterone:11-dehydrocorticosterone. All OVX-induced changes were restored with replacement of oestradiol, except that oestradiol lowered the zona fasciculata area of the adrenal gland, dampened corticosterone synthesis but increased cortisol synthesis. These data suggest that oestrogen partially attenuates the unconditioned fear response in mdx mice via adrenal and vascular function. It also suggests that partial dystrophin restoration in a dystrophin-deficient vertebrate is an effective approach to develop an appropriate hypertensive response to stress.
Similar content being viewed by others
Introduction
Brain dystrophin isoforms (Dp427, Dp260, Dp140, Dp116 and Dp71/Dp40) are transcribed in a tissue-dependent manner and perform several crucial processes1,2, such as regulating cerebral volume3, cellular stability via the dystrophin-glycoprotein-complex (DGC)4 and synaptic transmission5. A mutation in the gene encoding dystrophin (DMD gene) inhibits the expression and compromises the function of dystrophin. This disrupts various functions in the central nervous system (CNS). The severity of CNS disruption is associated with the location of the DMD gene mutation. For example, mutations in the Dp427 and Dp140/Dp71 variants are implicated in the severity of neurocognitive disabilities in humans affected by the terminal neuromuscular disease, Duchenne muscular dystrophy (DMD)6.
DMD is a X-linked disease affecting 1 in 5000 males7. DMD causes severe striated muscle degeneration that compromises the strength and capacity of the contractile tissue resulting in premature death due to cardiorespiratory failure. Up to 44% of patients with DMD suffer from brain-related co-morbidities8. These co-morbidities impact social development9,10 and associate with neurocognitive disability and worse prognostic outcomes11. Neurocognitive disabilities range from lower IQ, verbal and memory abnormalities, attention deficit hyperactivity disorder, anxiety, depression and autism12. In patients with DMD stress-inducing auditory and visual stimuli cause heightened levels of physiological anxiety, including fluctuations in heart rate and skin conductance compared to age-matched peers13. The intensity of physiological anxiety to stressful stimuli is correlated with the absence or expression of Dp14013.
The mdx mouse model of DMD does not express the Dp427 isoform due to a point mutation in exon 2314, causing it to suffer from muscle degeneration and a plethora of neurocognitive disabilities15,16. When challenged by a spectrum of stressful stimuli, a dysfunctional fear or threat response causes acute and sustained physical inactivity5,17,18, exacerbation of some dystrophinopathy phenotypes19,20 and cardiac failure due to hypotension21. This dysfunctional fear or threat response in mdx mice is driven by brain5,22 and skeletal muscle-sepcific dystrophin21,23. This is also associated with gamma-aminobutyric acid (GABA) receptor expression and activity5 and blood pressure21, respectively. During a stressor, mdx mice hyperactivate their hypothalamic–pituitary–adrenal (HPA)20,21 and renin–angiotensin–aldosterone (RAAS) axes20; a response significantly greater in female relative to male mdx mice20. Super-activation of the HPA and RAAS axis in female mdx mice is associated with greater resistance to stressful stimuli. Interestingly, this behaviour is abolished after ovariectomy and partially rescued with the replacement of oestradiol (E2)20.
The mechanisms controlling female sex hormone-dependent regulation of the stress response in mdx mice is unknown. Therefore, in study 1, we aimed to determine if blood pressure control can explain the difference in the dysfunctional fear or threat response of male and female mdx mice and if 30–60% dystrophin expression can rescue the dysfunctional fear or threat response in female mdx mice (heterozygous mice). In study 2, we aimed to understand how oestrogen regulates the dysfunctional fear or threat response in female mdx mice.
Materials and methods
Study 1
Experimental mice
Seven-week-old male and female C57BL/10ScSn-Dmdmdx/Arc (male mdx-hemi and female mdx-homo, respectively) and C57BL/10ScSn mice (wildtype; WT) were purchased from Animal Resources Centre (ARC; Perth, WA, Australia). Female heterozygous mdx mice (female mdx-het) were generated by mating male WT with mdx-homo in-house and genotyping was performed by Transnetyx (Cordova, TN, USA) on all female offspring. All mice were housed in groups of four per cage on a 12/12 h light/dark cycle with food and water provided ad libitum. Mdx mice were used as an experimental model of human DMD because they have a similar dysfunctional fear or threat response to mdx52 mice, which lack Dp427 and Dp14024. We previously showed that the fear or threat response in mdx mice is highly variable and associated with disease pathogenesis20. However, to ensure the biological variability of the behavioural responses were captured, we used large sample sizes and set no inclusion or exclusion criteria for the study.
Experimental design
Mice acclimated for 1 week prior to completing any experiment. At 8-weeks of age, male WT (n = 49), female WT (n = 42), female mdx-het (n = 77), male mdx-hemi (n = 119) and female mdx-homo (n = 117) mice completed three behavioural stressors, each separated by 1 week: forced downhill treadmill exercise, scruff-restraint and plexiglass-restraint (tube restraint; blood pressure analysis). Forced downhill treadmill exercise and scruff-restraint were accompanied by monitoring of physical activity before and immediately after the intervention. Male mdx-hemi and female mdx-homo mice also completed each stressor on two more occasions, each 1 week apart to assess habituation. For each genotype, a cage was selected randomly from the pool of all cages for completion of the stressors. Although time of day does not impact the behavioural response of mdx mice to stress20, testing order of mice was randomized daily. At the conclusion of the final plexiglass-restraint, all mice were killed by CO2 asphyxiation and cervical dislocation. Researchers were aware of mouse genotype throughout the conduction of experiments and data analyses.
Treadmill exercise
Mice were placed into an activity monitoring chamber to assess physical activity as previously described20. Mice were then run four at a time and the lanes of the treadmill were cleaned between each test. The treadmill was set at 0 m/min for two min before increasing to 10 m/min for 1 min. The treadmill increased by 1 m/min until 15 m/min was reached, which was then maintained for 15 min. At the completion of exercise, mice were again placed into a clean and sterilized activity monitoring chamber to assess physical activity.
Scruff-restraint
Mice were placed into an activity monitoring chamber to assess physical activity. Mice were then grasped by the nape between the thumb and index finger. The tail was placed between the fourth and fifth digit and the mouse was inverted such that it was in a supine orientation. The mouse remained in this position for 30 s. At the completion of the scruff-restraint, mice were again placed into a clean and sterilized activity monitoring chamber to assess physical activity because scent impacts activity of mdx mice following a stressor17.
Plexiglass-restraint (blood pressure)
Mice were placed into the CODA non-invasive blood pressure system for 5 min using the 25–50 g mouse holder (Kent Scientific, Torrington, CT, USA). The plexiglass restraint prevented the mouse moving in any direction and was adjusted to accommodate the size of each mouse. The restraint was placed on a 37 °C warming platform and a mouse sized tail cuff (8–75 g mouse) was placed on the tail, ensuring only the tip of the tail was visible for consistency across the cohorts. Blood pressure was automatically assessed every 30 s for 5 min (10 total measurement) using volume pressure recording (VPR) sensor technology and in-built CODA software. Mean arterial pressure as well as the shock index (maximum heart rate/low systolic blood pressure; index of hypovolemic stress) was used to assess stress sensitivity in mdx mice.
Physical activity monitoring
Physical activity was monitored using an Accuscan system by Omnitech Electronics, Inc. (Columbus, OH, USA). Physical activity was measured in the x, y and z planes using horizontal and vertical beam breaks. Mice were monitored four at one time and activity monitors were cleaned and sterilized prior to a mouse being placed in the chamber. Movement time (MT; s), vertical activity (VA; mouse rearing on its hind legs; counts), distance ambulated (DA; m), average velocity (m/s) and peak velocity (m/s) were used to assess physical activity levels. Data are either presented as the ratio of post-stressor physical activity compared to pre-stressor physical activity (% of intervention) or as a freezing % (total time spent immobile during the 5 min post-stress). Greater physical activity levels is associated with increased levels of resistance to behavioural stressors21.
Study 2
Experimental mice and design
Eight-week-old C57BL/10ScSn-Dmdmdx/Arc female mice (female mdx-homo) following a sham, ovariectomy (OVX) or OVX + E2 supplementation were purchased from the ARC (n = 15/group). The physical activity data in response to a series of behavioural stressors was previously published in these experimental mice20. All mice were housed in groups of four per cage on a 12/12 h light/dark cycle with food and water provided ad libitum. Mice acclimated for 1 week prior to completing a scruff restraint and forced downhill treadmill exercise test, followed 1 week later by another scruff restraint. Fifteen minutes later, serum and tissue were collected after CO2 asphyxiation and cervical dislocation. The order of testing was randomized both within and between each experimental group and researchers were aware of group allocation throughout the conduction of experiments and data analyses.
OVX and E2 pellet implantation
Mice (8-weeks-old) were anesthetized with an intraperitoneal injection of 75–100 mg/kg ketamine/xylazine (0.1 mL per 10 g mouse body mass). While anesthetized, mice were placed on a warming mat in ventral recumbency, injected subcutaneously with 0.05 mg/kg buprenorphine, hair removed from both flanks from the caudal rib to the femur, the surgical site disinfected with warmed chlorhexidine and a dorsoventral incision was made in the paralumbar fossa mid-way between the caudal rib and femur on both sides of the mouse through the skin and muscle wall. The ovary and oviduct were exteriorized through the incision and either removed by cauterizing between the uterine horn and the oviduct and cutting through the periovarian fat pad (OVX) or returned into the peritoneal cavity (sham). The muscle wall was then closed with absorbable suture and a 0.5 mL lignocaine (5 mg/kg) and bupivacaine (1.2 mg/kg) splash block administered to the incision site. A placebo (60-day release; 0.18 mg) or E2 pellet (60-day release; 0.18 mg; 3.4 µg/day) were then placed under the skin at the surgical site (Innovative Research of America, Sarasota, FL, USA). E2 concentrations reflect physiological hormone levels in mice25. Sterile wound clips closed the skin incision, mice received a 5 mg/kg subcutaneous carprofen injection, and 0.5 mL warmed lactated ringers solution subcutaneously. Supplemental heat was provided during recovery and animals were placed in home cages with access to floor feed, moisture sources and nesting materials. Wound clips were removed after 7–10 days and mice were shipped 2 weeks following surgery.
Physical activity monitoring
Performed according to Study 1.
Tissue collection
Tissue collection was completed according to our previous methods20. Mice were killed by CO2 asphyxiation followed by cervical dislocation. Trunk blood was collected by decapitating the mouse immediately after cervical dislocation and collecting into a sterile tube. Blood was allowed to clot for 30 min at room temperature before centrifugation at 20,000g for 10 min. Serum was removed and snap frozen in liquid nitrogen and stored at − 80 °C until analyses. Tibialis anterior (TA), diaphragm and adrenal glands were collected and frozen in liquid nitrogen cooled isopentane before storing at − 80 °C until histological analyses.
Histology
Tissue sections (8 µm) were stained with H&E for adrenal gland and skeletal muscle pathology (n = 5–8/stress group) as previously described26.
Collagen content
Tibialis anterior and diaphragm sections (8 µm mid-belly cryosections) were stained using the Trichrome Stain Kit according to the manufacturer’s instructions (Ab150686, Abcam, Sydney, Australia).
Visualization
All muscle and adrenal gland sections were visualized using a Nikon Eclipse Ti2 microscope (Nikon, Australia) and captured using a Nikon DS-Qi2 camera, powered by Nikon Elements software (Nikon). Adrenal and TA cross-sectional area in millimeters squared were measured by tracing the section border in ImageJ (NIH, Bethesda, MD). Central nucleated fibres in the TA (400–600 fibers; 3 sections located in the upper, middle and lower quadrants of the cross-section) and diaphragm (200–300 fibers; 3 sections located in the upper, middle and lower quadrants of the cross-section) were quantified in ImageJ. Diaphragm thickness was measured in ImageJ by taking an average of five measurements equally spaced along the length of the muscle section. Collagen content was determined using the colour thresholding function in ImageJ.
Metabolomics
Samples were extracted and analysed by LC–MS as previously described20. Sample extraction: serum samples were thawed on ice and 10 µL was aliquoted for analysis by liquid chromatography-mass spectrometry (LC–MS) by Metabolomics Australia (Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia). Samples were extracted using 180 µL 1:1 acetonitrile/methanol solution containing 2 µM 13C-sorbitol, 2 µM 13C, 15N-AMP and 2 µM 13C15N-UMP as internal standards. An additional 10 µL from each of the 40 serum samples was pooled for serum quality control (SQC) samples (10 µL), which were extracted with the serum samples. Samples were prepared in batches of 24, with a PQC extracted every ~ 10 sample. Samples were then vortexed for 30 s, incubated for 10 min at 4 °C using an Eppendorf Thermomixer and centrifuged at max speed for 10 min at 4 °C. After centrifugation, 60 µL of supernatant was transferred into a glass HPLC insert and 10 µL of the supernatant was pooled to create a pooled biological quality control (pbQC), which were all pooled post extraction and run as pbQC in the batches. LC–MS: Samples were stored in an autosampler at 4 °C, polar metabolites were separated by injecting a 10 μL sample onto a SeQuant ZIC-pHILIC column (150 mm × 4.6 mm, 5 μm) maintained at 30 °C using Solvent A (20 mM (NH4)2CO3, pH 9.0 (Sigma-Aldrich) and Solvent B (100% acetonitrile) at a flow rate of 300 μL/min and analysed on an Agilent 1200 series HPLC system (Agilent Technologies). The gradients used were: time (t) = 0 min, 80% B; t = 0.5 min, 80% B; t = 15.5 min, 50% B; t = 17.5 min, 30% B; t = 18.5 min, 5% B, t = 21.0 min, 5% B; t = 23 min, 80% B. The mass spectrometry analysis was performed on an Agilent 6545 series quadrupole time-of-flight mass spectrometer (QTOF MS) (Agilent Technologies). The LC flow was directed to an electrospray ionization source (ESI), where metabolite ionization in negative mode was performed with a capillary voltage of 2500 V, a drying gas (N2) pressure of 20 psi with a gas flow rate of 10.0 L/min, a gas temperature in the capillary of 325 °C and fragmentor and skimmer cap voltages of 125 V and 45 V, respectively. LC/MS data was collected in centroid mode with a scan range of 60–1200 m/z and an acquisition rate of 1.5 spectra/s in all-ion fragmentor (AIF) mode, which included three collision energies (0, 10, 20 V). Prior to analysis, mass calibration was performed for negative mode to 0.5 ppm accuracy of the m/z value. Internal mass calibration was performed using Agilent ESI-TOF Reference Mass Solution containing purine (119.036320) and hexakis (1H,1H,3H-tetrafluoropropoxy) phosphazine (981.99509) (API-TOF Reference Mass Solution Kit, Agilent Technologies), which was continuously flowed into the ESI source at a flow rate of 200 μL/min.
Corticosterone ELISA
Serum was analysed according to the manufacturer’s instructions (K014-H1, Arbor Assays, Ann Arbor, MI, USA).
Statistics
All analyses were conducted in GraphPad Prism 8.0.0 and there were no animal exclusions. Physical activity, blood pressure, metabolomics and muscle pathology were compared using either a one-way or two-way ANOVA and post-hoc Tukey’s test after checking for data normality. When data were not normally distributed, a Kruskal–Wallis test or Friedmann’s test were performed with Dunn’s post-hoc analysis, respectively. Linear regression was performed for correlative analyses between freezing time after treadmill exercise, scruff-restraint and mean arterial pressure. Data are presented as mean ± SD with significance set as p < 0.05.
Ethical approval
All studies were reviewed and approved by the Deakin University Animal Ethics Committee (G04-2020 and G09-2020). All animals were housed and treated in accordance with standards set by Deakin University Animal Welfare Committee, which complies with the ethical and governing principles outlined in the Australian code for the care and use of animals for scientific purposes. The study is reported in accordance with ARRIVE guidelines.
Results
Study 1
There was a genotype effect for the level of physical activity following forced downhill treadmill exercise (Fig. 1a; p < 0.001) and scruff-restraint (Fig. 1b; p < 0.001). In response to treadmill exercise, female WT mice were more active than male WT mice (p = 0.030) and female mdx-het mice were less active relative to WT mice of both sexes across multiple indices of physical activity (p < 0.001). Male mdx-hemi mice were less active compared to all other genotypes (p < 0.001) while female mdx-homo mice were less active relative to female WT mice (p = 0.009) and more active than female mdx-het mice (p = 0.020). In response to scruff-restraint, there was no difference in physical activity between male WT, female WT and female mdx-het mice (p ≥ 0.773). Male mdx-hemi and female mdx-homo mice were less active across all indices of physical activity relative to male WT, female WT and female mdx-het mice (p < 0.001) but male mdx-hemi mice were less active than female mdx-homo mice across four of the five physical activity parameters (p = 0.013 to < 0.001).
There was a genotype effect for blood pressure (Fig. 2a; p < 0.001) and shock index (Fig. 2b; p < 0.001) in response to plexiglass-restraint. No differences were detected in blood pressure between male WT, female WT and female mdx-het mice (p ≥ 0.111), with all showing a hypertensive response (142–161 mmHg)21. Male mdx-hemi mice became hypotensive during the plexiglass-restraint (86 mmHg) while mdx-homo mice remained normotensive (104 mmHg)21. Similarly, hypovolemic shock, or shock index, remained normal and indifferent between male WT, female WT and female mdx-het mice (p ≥ 0.208)21. Male mdx-hemi mice had a two-fold increase in shock index relative to male WT, female WT and female mdx-het mice (p < 0.001) and a 1.25-fold increase relative to female mdx-homo mice (p < 0.001).
Due to the high inter-individual response of mdx mice to behavioural stressors (Fig. 1, 2), we wanted to determine if the fear response of individual male mdx-hemi and female mdx-homo mice was uniform across multiple types of stressors. Using freezing time (%; time spent immobile) after treadmill exercise and scruff-restraint, as well as mean arterial pressure during the plexiglass-restraint, we completed correlative analyses and discovered no relationship in the fear response of male mdx-hemi (Fig. 3a–c; R2 = 0.001–0.040) and female mdx-homo mice (Fig. 3d–f; R2 < 0.001–0.027) to various stressors.
When challenged by repeated treadmill exercise and scruff-restraint stressors, male mdx-hemi and female mdx-homo mice did not adapt (Fig. 4a,b). The level of physical inactivity increased with each successive exposure for both male mdx-hemi and female mdx-homo mice (p ≤ 0.015), but female mdx-homo mice remained more physically active relative to male mdx-hemi mice across both stressors (p ≤ 0.014). In contrast, male mdx-hemi and female mdx-homo mice both became hypertensive following a second plexiglass-restraint exposure (Fig. 4c; 124–128 mmHg; p < 0.001) that did not change after a third (129–132 mmHg; p ≥ 0.300). No differences in mean arterial pressure were detected between male mdx-hemi and female mdx-homo mice following the repeated exposures (p ≥ 0.783). Similarly, shock index decreased for both male mdx-hemi and female mdx-homo mice after a second plexiglass-restraint exposure (p < 0.001) that did not change after a third (Fig. 4d; p ≥ 0.538). The shock index for mdx-hemi mice remained higher than female mdx-homo mice after the second exposure (p < 0.001) but not the third (p = 0.063).
Study 2
First, we evaluated the impact of OVX on female mdx-homo mice (Fig. 5a,b). There was a significant intervention effect on skeletal muscle mass (Fig. 5c; p = 0.026), with OVX lowering muscle mass relative to sham. The replacement of E2 in OVX mice normalised muscle mass. There was no effect of OVX or OVX + E2 on the cross-sectional area of the TA (Fig. 5d; p = 0.065), thickness of the diaphragm (Fig. 5e; p = 0.779) or number of central nucleated fibers in the TA or diaphragm (Fig. 5f; p = 0.452). OVX, or the replacement of E2 in OVX mice, did not affect collagen content in the TA or diaphragm muscle relative to sham mice (Fig. 5g; p ≥ 0.084).
Adrenal gland activity has been implicated in the stress response of mdx mice18,20,21 so we assessed the impact of OVX on adrenal gland morphology in female mdx-homo mice (Fig. 6a–c). OVX lowered adrenal mass (Fig. 6d; p = 0.003) and adrenal cross-sectional area (Fig. 6e; p = 0.002) relative to sham mice that was normalized with E2 replacement. OVX lowered the zona glomerulosa area that was rescued with E2 (Fig. 6f; p = 0.017) while the zona fasciculata area was not affected by OVX (p = 0.663) and trended toward lower in OVX + E2 mice (Fig. 6g; p = 0.074). OVX did not affect zona reticularis area relative to sham mice (Fig. 6h; p = 0.094) but the OVX + E2 group had greater zona reticularis area relative to sham mice (Fig. 6h; p = 0.008). There were no differences in medulla size between groups (Fig. 6i; p = 0.993).
To confirm differences in zona glomerulosa and zona fasciculata area between groups, we completed a metabolomic screen on serum collected 15 min following a 30 s scruff-restraint (Fig. 7a; Supplemental Table S1). Serum corticosterone was not affected by OVX but OVX + E2 showed a trend toward a lower concentration relative to sham and OVX (p = 0.07). To confirm the validity of the metabolomic screen, we also selected corticosterone to analyse via ELISA. Serum corticosterone was not affected by OVX but OVX + E2 lowered concentrations relative to sham and OVX (Fig. 7b; p < 0.001). The inactive derivative of corticosterone, 11-dehydrocorticosterone, was lower in OVX and OVX + E2 groups relative to sham (Fig. 7c; p < 0.001) while the corticosterone:11-dehydrocorticosterone was elevated in OVX relative to sham and partially rescued with E2 (Fig. 7d; p < 0.001). This steroidal biosynthesis resulted in a 50% reduction in aldosterone production in OVX mice relative to sham that was normalised in OVX + E2 mice (Fig. 7e; p = 0.031). Interestingly, the non-dominant branch of the HPA axis in rodents, cortisol production, was unaffected by OVX but elevated in OVX + E2 relative to sham (Fig. 7f; p = 0.011). This trend was not evident for the inactive form of cortisol, cortisone (Fig. 7g; p = 0.170), but the cortisol:cortisone was not affected by OVX but elevated by OVX + E2 (Fig. 7h: p = 0.030).
Discussion
The unconditioned fear or threat response in dystrophin-deficient vertebrates is robust but complex, with several associative mechanisms explaining or rescuing the phenotype5,17,20,21,22,23,27. Here, our understanding of the fear or threat response in mdx mice is expanded by showing a correlative relationship between vascular function, level of dystrophin expression (female mdx-het; striated muscle and brain17,28) and adrenal function with this behavioural phenotype.
Generation of a hypertensive response to a stressor contributes to an appropriate “fight-or-flight” response in normal physiology. When challenged by a severe stressor, dystrophin-deficiency kills the majority of male mdx mice due to sustained hypotension21. In this study female mdx-homo, relative to male mdx-hemi mice, remained normotensive during a stressor. This may explain their greater level of physical activity after stress and the consequence of their HPA and RAAS super activation after a stressor20. The hypotensive response of male mdx-hemi mice to plexiglass-restraint stress closely resembles blood pressure data from both scruff-restraint and social defeat stress in this mouse model21. However, male and female WT mice have a greater hypertensive response to plexiglass-restraint stress relative to scruff-restraint and social defeat. This suggests plexiglass-restraint stress elicits a greater stress response, or variability between the blood pressure tail cuff and radio-telemetry methodologies. Using the non-invasive blood pressure tail cuff method, female mdx-het mice, which express 30–60% dystrophin levels in skeletal muscle and brain17,28, generate a hypertensive response to stress and present with a WT-like shock index. These data suggest that 30–60% dystrophin expression in skeletal muscle is sufficient to normalise the vascular response to stress in a dystrophin-deficient mouse.
Data from this study indicates that oestrogen is necessary for normal adrenal gland mass, zona glomerulosa area of the adrenal gland and corresponding aldosterone production during a stressor in mdx mice. These data are like that described in WT rodents, where ovariectomy lowers adrenal gland mass29, decreases adrenal cortex activity30 and expands zona glomerulosa cells30. Oestradiol also increases aldosterone secretion in female rats31. In contrast, oestrogen does not appear necessary for zona fasciculata area in mdx mice, which corresponded with a lower corticosterone production during a stressor. This outcome suggests that progesterone, which is also abolished with OVX, is necessary to normalise the area of the zona fasciculata and corticosterone synthesis and that this is necessary to restore the physical activity response to moderate stressors such as scruff-restraint20. Interestingly, OVX + E2 mice had elevated levels of cortisol production, which are typically low in rodents but shown to be responsive to stress32. This elevation in OVX + E2 mice, relative to sham and OVX groups, may be a compensatory mechanism associated with low levels of corticosterone synthesis. OVX and OVX + E2 also resulted in a larger zona reticularis in female mdx-homo mice. This may be a compensatory response to upregulate androgen precursor synthesis and increase sex hormone production. Additionally, oestrogen partially stabilizes HPA activity via restoration of the corticosterone:11-dehydrocorticosterone. This is a response in mice that limits corticosterone production to prevent a heightened and prolonged stress response33. Collectively, these data suggest oestrogen, and by process of elimination, progesterone, are required to maintain normal adrenal morphology and function during a stressor that elicits an appropriate response to maintain normotension in mdx mice.
The hormonal, adrenal and vascular outcomes in this study support the peripheral hypothesis associated with the robust fear-related behavioural phenotype of mdx mice. The peripheral restoration of dystrophin (skeletal muscle-specific) in mdx mice prevents lethality during extreme stressors such as social defeat via generation of a hypertensive response21. Similarly, restoring dystrophin in skeletal muscle also rescues the unconditioned fear response in mdx mice to less severe stressors such as scruff-restraint. On the contrary, the central hypothesis, which centers on dystrophin restoration in the central nervous system5,22, partially rescues the response to mild stressors such as brief restraint stress in an expression-dependent manner. The partial rescue of this response is directly associated with brain-specific dystrophin expression and appears dependent on low (10–35% in brain homogenate in Zarrouki et al.22) or very low (~ 27% in the postsynaptic density fraction of brain homogenate in Sekiguchi et al.5) levels of expression. These studies, combined with the data presented in this study, suggest a relationship between stressor intensity, dystrophin expression levels and the contribution of peripheral and central mechanisms in the unconditioned fear response of mdx mice. However, it is unknown if blood pressure is affected by restoration of dystrophin in the central nervous system during a stressor and what impact 10–35% dystrophin expression has on the fear response during more extreme stress protocols. Convoluting these findings are the data presented here on mdx-het mice, which express 30–60% dystrophin in the central and peripheral tissues17,28 and have a WT-like response to the stressful stimuli in this study. Goyenvalle et al., who restored dystrophin expression in brain and striated muscle in mdx mice via intravenous administration of an antisense oligonucleotide made of tricyclo-DNA, also rescued the freezing response to scruff-restraint34. Thus, it remains challenging to determine what contribution central and peripheral mechanisms have on the heightened unconditioned fear response of mdx mice.
In response to plexiglass-restraint and scruff-restraint, female mdx-het mice showed comparable vascular function and physical activity to WT mice, respectively, which corroborates previous findings17. However, female mdx-het mice were less active than male and female WT mice in response to treadmill exercise. Treadmill exercise, a less severe stressor than a scruff-restraint in mdx mice20, causes anxiety-like symptoms in rodents35. These data suggest that female mdx-het have greater levels of anxiety relative to WT mice. Given human female carriers (women who carry a DMD gene mutation in one of their X-chromosomes) show comparable levels of neurocognitive disabilities to boys with DMD, including attention state36, these data suggest that anxiety may also be common in this population.
Consistent findings between studies show that mdx mice exhibit a hypersensitive fear response to stressors such as treadmill exercise, scruff-restraint, tube-restraint (plexiglass-restraint) and social defeat stress. However, evidence in this study and others20 indicate some mdx mice demonstrate a WT-like response to various stressors and that this response can be stressor-specific (i.e., a mouse that appears WT-like after scruff-restraint develops hypotension to plexiglass-restraint). Therefore, when designing experiments to assess the response of mdx mice to various stressors, either to understand the basic mechanisms of the fear response or to test genetic therapies, large cohorts of mdx mice and the inclusion of multiple stressors should be considered.
Male mdx-hemi mice appear not to adapt or habituate to daily stress18,19, although some adaptation may occur when the stress is applied multiple times within the same day18. In accordance with these previous findings, male mdx-hemi mice in this study did not adapt to weekly treadmill exercise or scruff-restraint. In fact, male mdx-hemi mice were less physically active after each successive stressor indicating their stress sensitivity continually increased. Similarly, female mdx-homo mice presented with a comparable response, also becoming increasingly more sensitive to treadmill exercise and scruff-restraint with repeated exposure. These levels of physical inactivity in mdx mice are like that observed in WT mice exposed to repeated scruff-restraints, where levels of physical inactivity also increased18. In contrast, the physical activity response to stressful stimuli in WT mice, which is dependent on age, also appears to positively adapt when the mouse is exposed to a chronic stress paradigm37. Interestingly, when exposed to the plexiglass-restraint stress, male mdx-hemi and female mdx-homo mice showed an adaptive cardiovascular response. Here, mean arterial blood pressure and shock index became more WT-like with successive exposures. It is plausible that physiological processes such as blood pressure, vs. behavioural manifestations such as physical activity, could have independent responses to stress when dystrophin is absent. A stressor-dependent effect may also influence habituation differences. For example, plexiglass-restraint is the only stressor where the mouse is not physically restrained or forced to exercise but is confined to a tube without human interference. Plexiglass-restraint is also considered less intense than a scruff-restraint when applied for 5 min18. In WT mice, mean arterial pressure increases during a stressor and repeated stressors results in a smaller increase in mean arterial pressure with successive stimuli, which is accompanied by a faster rate of recovery after the cessation of the stimuli38. These data suggest that while behaviour of dystrophin-deficient male and female mice does not adapt to repeated stress, physiological adaptations such as blood pressure could mitigate the potential for life-threatening episodes that mimic adaptations observed in WT mice.
The ovariectomy performed in this study was for 4–5 weeks, a period sufficient to lower striated muscle masses that was rescued with E2. The loss of muscle mass and rescue with E2 are like data generated in WT rodents and humans39,40. These data suggest that in a dystrophin-deficient environment, loss of the female sex hormones, like that observed during menopause, negatively impacts skeletal muscle size. In human female carriers, a spectrum of skeletal muscle weakness is observed41,42, that may progress with age41 and parallel a natural decrease in oestrogen availability. However, to the best of our knowledge, no data has indicated that menopause impacts muscle mass and/or strength in human female carriers, perhaps due to the large variability in skeletal muscle dystrophinopathies in this population43,44. Other indices of dystrophinopathy, such as central nucleated fibres, muscle thickness and muscle fibrosis, were not affected by ovariectomy. These data are in accordance with similar studies showing no difference in central nucleated fibres45 or collagen content46 in OVX female mdx-homo mice. This suggests that loss of the female sex hormones, for short periods of time (3–5 weeks), does not dramatically impact skeletal muscle pathology phenotypes of dystrophinopathy.
Conclusions
The unconditioned fear response in mdx mice is associated with an inability to generate a hypertensive response. This response appears normalised in female mdx-het mice (30–60% dystrophin expression in brain and striated muscle17,28) and is associated with an oestrogen-dependent relationship with adrenal gland morphology and function.
Data availability
Data will be made available upon reasonable request of the corresponding author.
References
Waite, A., Brown, S. C. & Blake, D. J. The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci. 35, 487–496 (2012).
Naidoo, M. & Anthony, K. Dystrophin Dp71 and the neuropathophysiology of Duchenne muscular dystrophy. Mol. Neurobiol. 2019(57), 1748–1767 (2019).
Yoshioka, M., Okuno, T., Honda, Y. & Nakano, Y. Central nervous system involvement in progressive muscular dystrophy. Arch. Dis. Child. 55, 589–594 (1980).
Blake, D. J., Hawkes, R., Benson, M. A. & Beesley, P. W. Different dystrophin-like complexes are expressed in neurons and glia. J. Cell Biol. 147, 645–658 (1999).
Sekiguchi, M. et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 132, 124–135 (2009).
Taylor, P. J. et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One 5, e8803 (2010).
Crisafulli, S. et al. Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis. Orphanet J. Rare Dis. 15, 141 (2020).
Banihani, R. et al. Cognitive and neurobehavioral profile in boys with Duchenne muscular dystrophy. J. Child Neurol. 30, 1472–1482 (2015).
Birnkrant, J. M., Bennett, D. S., Noritz, G. H. & Birnkrant, D. J. Developmental and behavioral disorders grown up: Duchenne muscular dystrophy. J. Dev. Behav. Pediatr. 32, 609–615 (2011).
Handberg, C., Werlauff, U. & Højberg, A. L. Perspectives on everyday life challenges of Danish young people with Duchenne muscular dystrophy (DMD) on corticosteroids. Glob. Qual. Nurs. Res. https://doi.org/10.1177/23333936221094858 (2022).
Mochizuki, H. et al. Mental retardation and lifetime events of Duchenne muscular dystrophy in Japan. Intern. Med. 47, 1207–1210 (2008).
Naidoo, M. & Anthony, K. Dystrophin Dp71 and the neuropathophysiology of Duchenne muscular dystrophy. Mol. Neurobiol. 57, 1748–1767 (2020).
Maresh, K. et al. Startle responses in Duchenne muscular dystrophy: A novel biomarker of brain dystrophin deficiency. Brain https://doi.org/10.1093/BRAIN/AWAC048 (2022).
Sicinski, P. et al. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 244, 1578–1580 (1989).
Lewon, M. et al. Evaluation of the behavioral characteristics of the mdx mouse model of Duchenne muscular dystrophy through operant conditioning procedures. Behav. Processes 142, 8–20 (2017).
Bagdatlioglu, E., Porcari, P., Greally, E., Blamire, A. M. & Straub, V. W. Cognitive impairment appears progressive in the mdx mouse. Neuromuscul. Disord. 30, 368–388 (2020).
Yamamoto, K. et al. Reduction of abnormal behavioral response to brief restraint by information from other mice in dystrophin-deficient mdx mice. Neuromuscul. Disord. 20, 505–511 (2010).
Vaillend, C. & Chaussenot, R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum. Mol. Genet. 26, 1041–1055 (2017).
Lindsay, A. et al. Some dystrophy phenotypes of dystrophin-deficient mdx mice are exacerbated by mild, repetitive daily stress. FASEB J. 35, e21489 (2021).
Lindsay, A. et al. Sensitivity to behavioral stress impacts disease pathogenesis in dystrophin-deficient mice. FASEB J. 35, e22034 (2021).
Razzoli, M. et al. Social stress is lethal in the mdx model of Duchenne muscular dystrophy. EBioMedicine 55, 102700 (2020).
Zarrouki, F. et al. Partial restoration of brain dystrophin and behavioral deficits by exon skipping in the muscular dystrophy X-linked (mdx) mouse. Ann. Neurol. https://doi.org/10.1002/ANA.26409 (2022).
Belanto, J. J. et al. Microtubule binding distinguishes dystrophin from utrophin. Proc. Natl. Acad. Sci. 111, 5723–5728 (2014).
Saoudi, A. et al. Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy. Dis. Model. Mech. 14, dmm049028 (2021).
Moran, A. L., Nelson, S. A., Landisch, R. M., Warren, G. L. & Lowe, D. A. Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice. J. Appl. Physiol. 102, 1387–1393 (2007).
Lindsay, A., Larson, A. A., Verma, M., Ervasti, J. M. & Lowe, D. A. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle. J. Appl. Physiol. 126, 363–375 (2019).
Matsuzaka, Y. et al. The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice. BMC Med. 18, 343 (2020).
Weller, B. et al. Inhibition of myosatellite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female heterozygote mice. Am. J. Pathol. 138, 1497 (1991).
Kuhn, G., Waldherr, R., Maser-Gluth, C., Hardegg, W. & Vecsei, P. Long-term effects of ovariectomy on pituitary-adrenal axis and specific antibody response in rats. Res. Exp. Med. 191, 327–337 (1991).
Saruhan, B. G. & Ozdemir, N. Effect of ovariectomy and of estrogen treatment on the adrenal gland and body weight in rats. Saudi Med. J. 26, 1705–1709 (2005).
Kau, M. M. et al. Effects of estradiol on aldosterone secretion in ovariectomized rats. J. Cell. Biochem. 73, 137–144 (1999).
Gong, S. et al. Dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice. PLoS One 10, e0117503–e0117503 (2015).
Hamden, J. E. et al. Measurement of 11-dehydrocorticosterone in mice, rats and songbirds: Effects of age, sex and stress. Gen. Comp. Endocrinol. 281, 173–182 (2019).
Goyenvalle, A. et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nat. Med. 21, 270–275 (2015).
Leasure, J. L. & Jones, M. Forced and voluntary exercise differentially affect brain and behavior. Neuroscience 156, 456–465 (2008).
Demirci, H. et al. Cognition of the mothers of patients with Duchenne muscular dystrophy. Muscle Nerve 62, 710–716 (2020).
Sadler, A. M. & Bailey, S. J. Repeated daily restraint stress induces adaptive behavioural changes in both adult and juvenile mice. Physiol. Behav. 167, 313–323 (2016).
Bernatova, I., Key, M. P., Lucot, J. B. & Morris, M. Circadian differences in stress-induced pressor reactivity in mice. Hypertension 40, 768–773 (2002).
Tiidus, P. M., Lowe, D. A. & Brown, M. Estrogen replacement and skeletal muscle: Mechanisms and population health. J. Appl. Physiol. 115, 569–578 (2013).
Collins, B. C., Laakkonen, E. K. & Lowe, D. A. Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength. Bone 123, 137–144 (2019).
Soltanzadeh, P. et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul. Disord. 20, 499–504 (2010).
Grain, L. et al. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul. Disord. 11, 186–191 (2001).
Nozoe, K. T. et al. Phenotypic contrasts of Duchenne Muscular Dystrophy in women: Two case reports. Sleep Sci. (Sao Paulo, Brazil) 9, 129–133 (2016).
Sewry, C. A. et al. Manifesting carriers of Xp21 muscular dystrophy; lack of correlation between dystrophin expression and clinical weakness. Neuromuscul. Disord. 3, 141–148 (1993).
Kosir, A. M. et al. Influence of ovarian hormones on strength loss in healthy and dystrophic female mice. Med. Sci. Sports Exerc. 47, 1177–1187 (2015).
Salimena, M. C., Lagrota-Candido, J. & Quírico-Santos, T. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem. Cell Biol. 122, 435–444 (2000).
Acknowledgements
This study used NCRIS-enabled Metabolomics Australia infrastructure at the University of Melbourne and funded through BioPlatforms Australia.
Funding
This work was supported by the Institute for Physical Activity and Nutrition [Seed Funding, AL]; and the Neurological Foundation [Philip Wrightson Fellowship, AL]. The funding agencies had no input in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
A.L. conceived and designed the study, performed experiments and prepared the manuscript; A.R. interpreted data and critically reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
Angus Lindsay is paid to consult on therapies for muscular dystrophies (LYNK). Aaron Russell has no conflict of interest to declare.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lindsay, A., Russell, A.P. The unconditioned fear response in dystrophin-deficient mice is associated with adrenal and vascular function. Sci Rep 13, 5513 (2023). https://doi.org/10.1038/s41598-023-32163-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-32163-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.